<unk> s <unk> s) are a class of medication that act as anticoagulants (delaying blood clotting) by directly inhibiting the enzyme<unk> . Some are in clinical use, while others are undergoing clinical development. Several members of the class are expected to replace heparin (and derivatives) and warfarin in various clinical scenarios.
Direct thrombin inhibitor
Direct Xa inhibitor
Vitamin K antagonist
Glycoprotein IIb/IIIa inhibitors
Factor Xa inhibitor antidote
Thrombolytic drug
Antiplatelet drug
Phosphodiesterase inhibitors